Sponsored by  Diabetes Vaccine Being Tested  Designed to reduce
or eliminate the need for insulin.  Three million Americans are
living with type 1 diabetes, once known as juvenile diabetes.
These patients need to inject themselves with insulin every day
to stay alive. Now, for the first time, a promising therapy may
stop the disease in its tracks.  Every second of every day,
Spike Loy has to think about his blood sugar. He was diagnosed
with type 1 diabetes when he was 7.  "My mom tested me for
years," Loy said.  Now, he tests himself up to 10 times a day
and has to worry about potential complications like nerve
damage, blindness, and stroke. However, Stanford researchers are
now studying a vaccine that could reverse the disease.  "We saw
some very exciting outcome measures," Larry Steinman, MD
Professor of Pediatrics and Neurology, Stanford University said.
In type 1 diabetes, the immune system stops beta cells from
making insulin. The vaccine uses DNA to attract and attack the
bad cells that destroy insuli